UPDATE: Citi Downgrades Gilead Sciences (GILD) to Neutral

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/2/2026

1. PANW
2. GTLB
3. MDB
4. DELL
5. SPY
6. MMED
7. CRDO
8. GOOGL
9. AAPL
10. NVDA

February 12, 2019 2:50 AM EST
Get Alerts GILD Hot Sheet
Price: $149.72 -0.13%

Rating Summary:
    36 Buy, 7 Hold, 1 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 4 | Down: 8 | New: 31
Join SI Premium – FREE
(Updated - February 12, 2019 3:27 AM EST)

(updated to add analyst comment)

Citi analyst Robyn Karnauskas downgraded Gilead Sciences (NASDAQ: GILD) from Buy to Neutral with a price target of $75.00 (from $100.00).

The analyst steps to the sidelines after admitting error on an expectation for NASH to work. She says without NASH the company will now need to rely on M&A to grow.

For an analyst ratings summary and ratings history on Gilead Sciences click here. For more ratings news on Gilead Sciences click here.

Shares of Gilead Sciences closed at $67.62 yesterday.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Analyst Comments, Analyst PT Change, Downgrades, Hot Downgrades

Related Entities

Citi